VCM
GRI

Vanguard Capital Management’s GRI Bio GRI Stock Holding History

Vanguard Capital Management’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.8K Buy
+21,368
New +$47.3K ﹤0.01% 3961

Other funds holding GRI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Vanguard Capital Management's GRI Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in GRI Bio (GRI) in Q2 2026: 21,368 shares worth $37.8K. The stake represents ﹤0.01% of the portfolio and ranks #3961 among its holdings.

8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Vanguard Capital Management held 21,368 shares of GRI Bio worth $37.8K as of Q2 2026.
  • GRI Bio was a new Vanguard Capital Management position in Q2 2026.
  • GRI Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3961 holding.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.